FDA Inspection
Qilu Pharmaceutical Co., Ltd. (Biological Industrial Park)Qilu Pharmaceutical Co., Ltd. (Biological Industrial Park) – FDA Inspection, Jun 9, 2023
Record Details
This FDA Inspection record concerns Qilu Pharmaceutical Co., Ltd. (Biological Industrial Park), with an inspection on June 9, 2023, issued by the Office of Inspections and Investigations.
- Inspection Date
- June 9, 2023
View Company Profile
ID · c12853c6-7a01-461a-82d2-2b8f87d20c75
Inspection Facts
- Inspection number
- 1209772
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.188(b)(12)Investigations made into any unexplained discrepancy
- 21 CFR 211.42(c)(10)Aseptic Processing Area
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Qilu Pharmaceutical Co., Ltd. (Biological Industrial Park)
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 8, 2026 | Not classified | Office of Inspections and Investigations | |
| June 28, 2019 | Not classified | Office of Inspections and Investigations | |
| March 1, 2019 | Not classified | Office of Inspections and Investigations |
Other documents for Qilu Pharmaceutical Co., Ltd. (Biological Industrial Park)
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.